Nanexa
1.265
SEK
-1.94 %
Less than 1K followers
NANEXA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
-1.94%
-15.67%
-41.44%
-54.82%
-29.33%
+26.5%
-54.98%
-79.96%
-84.54%
Nanexa is a drug delivery company with a proprietary platform that is used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The PharmaShell process is based on ALD (Atomic Layer Deposition) technology, which encloses pharmaceutical particles with a thin shell and creates opportunities for pharmaceutical companies to develop new products. Nanexa has cooperation with several pharmaceutical companies, mainly around the Nordic market.
Read moreMarket cap
198.49M SEK
Turnover
537.45K SEK
Revenue
24.36M
EBIT %
-106.98 %
P/E
-
Dividend yield-%
-
Financial calendar
6.5
2025
Interim report Q1'25
15.5
2025
General meeting '25
27.8
2025
Interim report Q2'25
ShowingAll content types
Nanexa publishes year-end report and Q4 report 2024
Nomination Committee for the 2025 Annual General Meeting in Nanexa AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools